Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study
- PMID: 32902783
- PMCID: PMC7479389
- DOI: 10.1007/s10554-020-02010-4
Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study
Abstract
Biological cardiac injury related to the Severe Acute Respiratory Syndrome Coronavirus-2 infection has been associated with excess mortality. However, its functional impact remains unknown. The aim of our study was to explore the impact of biological cardiac injury on myocardial functions in patients with COVID-19. 31 patients with confirmed COVID-19 (CoV+) and 16 controls (CoV-) were prospectively included in this observational study. Demographic data, laboratory findings, comorbidities, treatments and myocardial function assessed by transthoracic echocardiography were collected and analysed in CoV+ with (TnT+) and without (TnT-) elevation of troponin T levels and compared with CoV-. Among CoV+, 13 (42%) exhibited myocardial injury. CoV+/TnT + patients were older, had lower diastolic arterial pressure and were more likely to have hypertension and chronic renal failure compared with CoV+/TnT-. The control group was comparable except for an absence of biological inflammatory syndrome. Left ventricular ejection fraction and global longitudinal strain were not different among the three groups. There was a trend of decreased myocardial work and increased peak systolic tricuspid annular velocity between the CoV- and CoV + patients, which became significant when comparing CoV- and CoV+/TnT+ (2167 ± 359 vs. 1774 ± 521%/mmHg, P = 0.047 and 14 ± 3 vs. 16 ± 3 cm/s, P = 0.037, respectively). There was a decrease of global work efficiency from CoV- (96 ± 2%) to CoV+/TnT- (94 ± 4%) and then CoV+/TnT+ (93 ± 3%, P = 0.042). In conclusion, biological myocardial injury in COVID 19 has low functional impact on left ventricular systolic function.
Keywords: COVID-19; Myocardial work.; SARS-CoV-2; Speckle tracking echocardiography; Strain.
Conflict of interest statement
Olivier Lairez has received personal compensation for speaking with General Electric. The other co-authors have no conflict of interest to disclose.
Figures


Similar articles
-
Myocardial Inflammation and Dysfunction in COVID-19-Associated Myocardial Injury.Circ Cardiovasc Imaging. 2021 Jan;14(1):e012220. doi: 10.1161/CIRCIMAGING.120.011713. Epub 2021 Jan 19. Circ Cardiovasc Imaging. 2021. PMID: 33463366
-
Elevated Extracellular Volume Fraction and Reduced Global Longitudinal Strains in Participants Recovered from COVID-19 without Clinical Cardiac Findings.Radiology. 2021 May;299(2):E230-E240. doi: 10.1148/radiol.2021203998. Epub 2021 Jan 12. Radiology. 2021. PMID: 33434112 Free PMC article.
-
Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury.Infection. 2021 Jun;49(3):491-500. doi: 10.1007/s15010-020-01572-8. Epub 2021 Jan 30. Infection. 2021. PMID: 33515390 Free PMC article.
-
Heart, COVID-19, and echocardiography.Echocardiography. 2020 Sep;37(9):1454-1464. doi: 10.1111/echo.14834. Epub 2020 Sep 4. Echocardiography. 2020. PMID: 32885490 Review.
-
Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients.Echocardiography. 2020 Aug;37(8):1278-1286. doi: 10.1111/echo.14779. Epub 2020 Jul 12. Echocardiography. 2020. PMID: 32654210 Free PMC article. Review.
Cited by
-
Transthoracic Echocardiography-Based Prediction Model of Adverse Event Risk in Patients with COVID-19.Pathophysiology. 2022 Apr 26;29(2):157-172. doi: 10.3390/pathophysiology29020014. Pathophysiology. 2022. PMID: 35645324 Free PMC article.
-
COCARDE Study-Cardiac Imaging Phenotype in Patients With COVID-19: Protocol for a Prospective Observational Study.JMIR Res Protoc. 2022 Jan 6;11(1):e24931. doi: 10.2196/24931. JMIR Res Protoc. 2022. PMID: 34751159 Free PMC article.
-
Evaluation of myocardial work and exercise capacity in patients recovered from the severe form of COVID-19.Int J Cardiol Cardiovasc Risk Prev. 2024 Aug 19;23:200324. doi: 10.1016/j.ijcrp.2024.200324. eCollection 2024 Dec. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 39258008 Free PMC article.
-
[Echocardiography in the acute phase of COVID-19 infection: impact on management and prognosis].Rev Esp Cardiol. 2022 Jun;75(6):532-535. doi: 10.1016/j.recesp.2021.11.031. Epub 2022 Jan 17. Rev Esp Cardiol. 2022. PMID: 35068655 Free PMC article. Spanish. No abstract available.
-
Echocardiography in the acute phase of COVID-19 infection: impact on management and prognosis.Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):532-535. doi: 10.1016/j.rec.2021.11.012. Epub 2021 Dec 14. Rev Esp Cardiol (Engl Ed). 2022. PMID: 34972647 Free PMC article. No abstract available.
References
-
- Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J. Biol. Regul. Homeost. Agents. 2020;34:1. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous